Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by W Guan
Differential Effect of MMSET mRNA Levels on Survival to First-Line FOLFOX and Second-Line Docetaxel in Gastric Cancer
British Journal of Cancer
Cancer Research
Oncology
Genotype-Guided Tacrolimus Dosing in African-American Kidney Transplant Recipients
Pharmacogenomics Journal
Molecular Medicine
Genetics
Pharmacology
Related publications
Tumor BRCA1, RRM1 and RRM2 mRNA Expression Levels and Clinical Response to First-Line Gemcitabine Plus Docetaxel in Non-Small-Cell Lung Cancer Patients
PLoS ONE
Multidisciplinary
The Effect of Therapeutic Anticoagulation on Overall Survival in Men Receiving First-Line Docetaxel Chemotherapy for Metastatic Castration-Resistant Prostate Cancer
Clinical Genitourinary Cancer
Oncology
Urology
Comparative Analysis of the Efficacy and Safety of Modified FOLFOX-6 and DCF Regimens as First-Line Treatment in Advanced Gastric Cancer
Molecular and Clinical Oncology
Cancer Research
Oncology
Oxaliplatin, 5-Fluorouracil and Leucovorin (Modified FOLFOX-6) as First-Line Chemotherapy for Advanced Gastric Cancer Patients With Poor Performance Status
Oncology Letters
Cancer Research
Oncology
A Phase II Study of Modified FOLFOX as First-Line Chemotherapy for Metastatic Gastric Cancer in Elderly Patients With Associated Diseases
Gastric Cancer
Cancer Research
Medicine
Oncology
Gastroenterology
Combined Effect of Sodium Selenite and Docetaxel on PC3 Metastatic Prostate Cancer Cell Line
Biochemical and Biophysical Research Communications
Biochemistry
Cell Biology
Molecular Biology
Biophysics
Survival Benefits of Second-Line Axitinib Versus Everolimus After First Line Sunitinib Treatment in Metastatic Renal Cell Carcinoma
Pathology and Oncology Research
Medicine
Forensic Medicine
Pathology
Oncology
Cancer Research
Second-Line Treatment of Advanced Gastric Cancer: Where Do We Stand?
Journal of the National Comprehensive Cancer Network : JNCCN
Medicine
Oncology
FOLFOX as Second-Line Chemotherapy in Patients With Pretreated Metastatic Pancreatic Cancer From the FIRGEM Study
BMC Cancer
Cancer Research
Oncology
Genetics